Title : Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway.

Pub. Date : 2014

PMID : 24865582






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway. Cisplatin mitogen-activated protein kinase 8 Homo sapiens
2 These results suggest that the JNK-1/c-Jun/miR-21 pathway contributes to the cisplatin resistance of ovarian cancer cells and demonstrated that miR-21 is a plausible target to overcome cisplatin resistance. Cisplatin mitogen-activated protein kinase 8 Homo sapiens
3 These results suggest that the JNK-1/c-Jun/miR-21 pathway contributes to the cisplatin resistance of ovarian cancer cells and demonstrated that miR-21 is a plausible target to overcome cisplatin resistance. Cisplatin mitogen-activated protein kinase 8 Homo sapiens